Dr. Atanas Kamburov is a leader in cancer genomics and data science, with expertise spanning drug discovery, cancer biology, big data science, and network biology. Currently, he heads the Pharma Solutions team at Owkin that leverages multimodal AI models to find the right populations for drugs along with their respective biomarkers, identify biomarkers in routinely generated clinical data, and optimize the probability of success of clinical trials. With prior leadership roles at Bayer and academic experience at institutions like the Broad Institute, Harvard, and Max Planck Institute, Dr. Kamburov has authored over 40 publications, driving innovation in precision oncology and translational research.